InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Verrica Pharmaceuticals Inc.

VRCA Clue Score72
United States Fiscal year ends December CIK 0001660334
$4.11 -1.67% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $4.11 −66.80% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 15 Jun 2018. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2017Operating income−4.5Net income−4.5Fiscal year 2018Operating income−21.9Net income−20.6Fiscal year 2019Operating income−30.1Net income−28.2Fiscal year 2020Operating income−40.2Net income−42.7Fiscal year 2021Revenue12.0Operating income−30.9Net income−35.1EPS, diluted−1.30Fiscal year 2022Revenue9.0 −24.7%Operating income−21.3Net income−24.5EPS, diluted−0.72Fiscal year 2023Revenue5.1 −43.3%Operating income−65.8Net income−67.0EPS, diluted−1.48Fiscal year 2024Revenue7.6 +47.7%Operating income−65.9Net income−76.6EPS, diluted−14.78Fiscal year 2025Revenue35.6 +370.2%Operating income−12.2Net income−17.9EPS, diluted−1.68
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue n/a n/a n/a n/a 12.0 9.0 5.1 7.6 35.6
Growth −24.7% −43.3% +47.7% +370.2%
Operating income −4.5 −21.9 −30.1 −40.2 −30.9 −21.3 −65.8 −65.9 −12.2
Net income −4.5 −20.6 −28.2 −42.7 −35.1 −24.5 −67.0 −76.6 −17.9
Growth
EPS, diluted n/a n/a n/a n/a −1.30 −0.72 −1.48 −14.78 −1.68

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2017Fiscal year 2018Fiscal year 2019Fiscal year 2020Fiscal year 2021Operating margin−257.6%Net margin−292.3%Free cash flow margin−237.2%Fiscal year 2022Operating margin−235.8%Net margin−271.1%Free cash flow margin−209.8%Fiscal year 2023Operating margin−1,283.4%Net margin−1,307.5%Free cash flow margin−759.9%Fiscal year 2024Operating margin−871.3%Net margin−1,012.1%Free cash flow margin−805.6%Fiscal year 2025Operating margin−34.2%Net margin−50.3%Free cash flow margin−49.5%
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin n/a n/a n/a n/a −257.6% −235.8% −1,283.4% −871.3% −34.2%
Net margin n/a n/a n/a n/a −292.3% −271.1% −1,307.5% −1,012.1% −50.3%
Free cash flow margin n/a n/a n/a n/a −237.2% −209.8% −759.9% −805.6% −49.5%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2017Operating cash flow−4.6Fiscal year 2018Operating cash flow−17.9Capital expenditure−0.8Free cash flow−18.6Fiscal year 2019Operating cash flow−27.4Capital expenditure−0.7Free cash flow−28.1Fiscal year 2020Operating cash flow−30.2Capital expenditure−1.5Free cash flow−31.7Fiscal year 2021Operating cash flow−27.6Capital expenditure−0.9Free cash flow−28.5Fiscal year 2022Operating cash flow−18.7Capital expenditure−0.3Free cash flow−19.0Fiscal year 2023Operating cash flow−38.6Capital expenditure−0.4Free cash flow−38.9Fiscal year 2024Operating cash flow−60.9Capital expenditure−0.0Free cash flow−61.0Fiscal year 2025Operating cash flow−17.6Capital expenditure0.0Free cash flow−17.6
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −4.6 −17.9 −27.4 −30.2 −27.6 −18.7 −38.6 −60.9 −17.6
Capital expenditure n/a −0.8 −0.7 −1.5 −0.9 −0.3 −0.4 −0.0 0.0
Free cash flow n/a −18.6 −28.1 −31.7 −28.5 −19.0 −38.9 −61.0 −17.6
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2017Cash8.7Shareholders’ equity−7.0Fiscal year 2018Cash10.3Shareholders’ equity89.4Fiscal year 2019Cash9.2Shareholders’ equity65.0Fiscal year 2020Cash10.7Shareholders’ equity33.0Fiscal year 2021Cash15.8Shareholders’ equity32.6Fiscal year 2022Cash34.3Total debt0.0Net cash (debt)34.3Shareholders’ equity40.0Debt to equity0.00Fiscal year 2023Cash69.5Total debt42.9Net cash (debt)26.7Shareholders’ equity19.8Debt to equity2.17Fiscal year 2024Cash46.3Total debt43.9Net cash (debt)2.4Shareholders’ equity−9.9Fiscal year 2025Cash30.1Total debt0.0Net cash (debt)30.1Shareholders’ equity24.7Debt to equity0.00
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 8.7 10.3 9.2 10.7 15.8 34.3 69.5 46.3 30.1
Total debt n/a n/a n/a n/a n/a 0.0 42.9 43.9 0.0
Net cash (debt) n/a n/a n/a n/a n/a 34.3 26.7 2.4 30.1
Shareholders’ equity −7.0 89.4 65.0 33.0 32.6 40.0 19.8 −9.9 24.7
Debt to equity n/a n/a n/a n/a n/a 0.00 2.17 n/a 0.00

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Cash flow

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024† 31 Dec 2024 FY2025† 31 Dec 2025
Operations
−4.6 −17.9 −27.4 −30.2 −27.6 −18.7 −38.6 −60.9 −17.6
Growth
Investment
n/a −0.8 −0.7 −1.5 −0.9 −0.3 −0.4 −0.0 0.0
calc n/a −18.6 −28.1 −31.7 −28.5 −19.0 −38.9 −61.0 −17.6
Growth
calc n/a n/a n/a n/a −1.05 −0.55 −0.86 −11.77 −1.65
n/a −79.9 26.0 −3.6 −1.0 54.0 −0.4 −0.0 0.0
Financing
12.7 99.4 0.4 35.2 33.6 −16.9 74.2 37.7 1.4

† The diluted share count jumps at 2024 and 2025, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Lines marked calc are worked out here from filed figures; point at one for how. Capital expenditure, dividends and buybacks are shown as money out, so negative.